Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1990 2
1991 7
1992 4
1993 9
1994 7
1995 13
1996 8
1997 3
1998 10
1999 6
2000 5
2001 8
2002 5
2003 2
2004 6
2005 3
2006 2
2007 1
2008 1
2009 2
2011 2
2012 1
2014 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
DES exposure: an update.
Mittendorf R, Herbst AL. Mittendorf R, et al. Contemp Pediatr. 1994 Nov;11(11):59-62, 64, 66 passim. Contemp Pediatr. 1994. PMID: 10150281 Review.
Risk-benefit effects of tocolytic therapy.
Pryde PG, Janeczek S, Mittendorf R. Pryde PG, et al. Among authors: mittendorf r. Expert Opin Drug Saf. 2004 Nov;3(6):639-54. doi: 10.1517/14740338.3.6.639. Expert Opin Drug Saf. 2004. PMID: 15500422 Review.
The magpie trial.
Mittendorf R, Pryde PG, Herschel M, Lee KS. Mittendorf R, et al. Lancet. 2002 Oct 26;360(9342):1330-1; author reply 1331-2. doi: 10.1016/S0140-6736(02)11323-7. Lancet. 2002. PMID: 12414229 No abstract available.
Adverse and beneficial effects of tocolytic therapy.
Pryde PG, Besinger RE, Gianopoulos JG, Mittendorf R. Pryde PG, et al. Among authors: mittendorf r. Semin Perinatol. 2001 Oct;25(5):316-40. doi: 10.1053/sper.2001.27547. Semin Perinatol. 2001. PMID: 11707019 Review.
109 results